Molecure Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	16.35	18.19	63.99	65.62	102.04
Cash & Short-Term Investments	16.35	18.19	63.99	65.62	102.04
Cash Growth	-10.11%	-71.58%	-2.48%	-35.69%	-15.32%
Accounts Receivable	0.87	32.07	1.72	2.51	1.45
Other Current Assets	0	0	0	6.87	12.45
Total Current Assets	17.22	50.26	65.71	74.99	115.94
Net Property, Plant & Equipment	6.65	9.49	10.6	11.63	10
Other Intangible Assets	70.56	53.97	35.96	5.21	25.65
Long-Term Investments	0.01	-	-	-	-
Total Assets	94.43	113.72	112.27	91.82	151.59
Accounts Payable	0.89	1.83	3.02	2.82	1.99
Accrued Expenses	-	0.67	0.7	0.64	0.77
Current Portion of Leases	2.03	2.18	2.16	2.21	1.81
Unearned Revenue	0.02	0.02	0.05	0.04	0.36
Other Current Liabilities	0.66	1.19	0.86	2.03	2.34
Total Current Liabilities	3.6	5.12	6.04	6.98	6.16
Long-Term Leases	3.27	5.05	4.98	4.2	4.2
Other Long-Term Liabilities	0.12	0.15	0.33	0.43	0.08
Total Long-Term Liabilities	3.39	5.2	5.3	4.63	4.28
Total Liabilities	6.99	10.31	11.34	11.61	10.45
Common Stock	0.21	0.2	0.17	0.14	0.14
Additional Paid-in Capital	184.43	180.39	150.71	101.2	98.15
Accumulated Other Comprehensive Income	0	4.09	0.04	0.49	2.97
Retained Earnings	-97.19	-81.28	-49.99	-21.62	39.88
Shareholders' Equity	87.45	103.41	100.93	80.21	141.14
Total Liabilities & Equity	94.43	113.72	112.27	91.82	151.59
Total Debt	5.29	7.23	7.14	6.41	6.01
Net Cash (Debt)	11.06	10.96	56.85	59.21	96.03
Net Cash Growth	0.92%	-80.73%	-3.99%	-38.34%	-16.69%
Net Cash Per Share	0.54	0.54	3.38	4.22	6.88
Book Value	87.45	103.41	100.93	80.21	141.14
Book Value Per Share	4.27	5.12	5.99	5.72	10.11
Tangible Book Value	16.89	49.43	64.97	75	115.49
Tangible Book Value Per Share	0.83	2.45	3.86	5.35	8.28